The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios

No Thumbnail Available

Click here to download

0843.htm (3.28 KB)

Date

2016

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Neuroendocrine tumor, Peptide receptor radionuclide therapy, 68Ga-DOTATATE, FDG-PET/CT, Chemotherapy, 177Lu-DOTATATE

Source

European Journal of Nuclear Medicine and Molecular Imaging, 2016. Vol. 43 (13): pp. 2453-2455

URI

http://hdl.handle.net/123456789/14153

Collections

2016